Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Sells Microarray Synthesizer to Keio University

NEW YORK, April 15 - Acacia Research subsidiary CombiMatrix today said that it has sold a custom slide-chip DNA microarray synthesizer to the Keio University School of Medicine in Tokyo, Japan.

 

The department of molecular biology at Keio University, which has also agreed to purchase microarrays from CombiMatrix, plans to use the synthesizer in combination with its own high-fidelity digital hybridization screening techniques to screen clones for sequencing tag sites in the human genome as well as the genomes "of a variety of commercially important organisms."

 

Under the terms of the agreement, CombiMatrix and the university will jointly benefit from the commercialization of any content, candidates, or products discovered as part of this research.

 

CombiMatrix's Japanese subsidiary announced another sale last week to Nihon Gene Research Laboratory (NGRL) in Sendai.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.